169 related articles for article (PubMed ID: 35637316)
1. Development of an efficient single-cell cloning and expansion strategy for genome edited induced pluripotent stem cells.
Bhargava N; Thakur P; Muruganandam TP; Jaitly S; Gupta P; Lohani N; Goswami SG; Saravanakumar V; Bhattacharya SK; Jain S; Ramalingam S
Mol Biol Rep; 2022 Aug; 49(8):7887-7898. PubMed ID: 35637316
[TBL] [Abstract][Full Text] [Related]
2. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.
Gupta N; Susa K; Yoda Y; Bonventre JV; Valerius MT; Morizane R
Curr Protoc Stem Cell Biol; 2018 May; 45(1):e50. PubMed ID: 30040245
[TBL] [Abstract][Full Text] [Related]
4. Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression.
Li XL; Li GH; Fu J; Fu YW; Zhang L; Chen W; Arakaki C; Zhang JP; Wen W; Zhao M; Chen WV; Botimer GD; Baylink D; Aranda L; Choi H; Bechar R; Talbot P; Sun CK; Cheng T; Zhang XB
Nucleic Acids Res; 2018 Nov; 46(19):10195-10215. PubMed ID: 30239926
[TBL] [Abstract][Full Text] [Related]
5. Genome Editing in Human Induced Pluripotent Stem Cells (hiPSCs).
Higo S; Hikoso S; Miyagawa S; Sakata Y
Methods Mol Biol; 2021; 2320():235-245. PubMed ID: 34302662
[TBL] [Abstract][Full Text] [Related]
6. Integration of xeno-free single-cell cloning in CRISPR-mediated DNA editing of human iPSCs improves homogeneity and methodological efficiency of cellular disease modeling.
Namipashaki A; Pugsley K; Liu X; Abrehart K; Lim SM; Sun G; Herold MJ; Polo JM; Bellgrove MA; Hawi Z
Stem Cell Reports; 2023 Dec; 18(12):2515-2527. PubMed ID: 37977144
[TBL] [Abstract][Full Text] [Related]
7. Improving single-cell cloning workflow for gene editing in human pluripotent stem cells.
Chen YH; Pruett-Miller SM
Stem Cell Res; 2018 Aug; 31():186-192. PubMed ID: 30099335
[TBL] [Abstract][Full Text] [Related]
8. Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing.
Adkar SS; Wu CL; Willard VP; Dicks A; Ettyreddy A; Steward N; Bhutani N; Gersbach CA; Guilak F
Stem Cells; 2019 Jan; 37(1):65-76. PubMed ID: 30378731
[TBL] [Abstract][Full Text] [Related]
9. Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells.
Molugu K; Khajanchi N; Lazzarotto CR; Tsai SQ; Saha K
CRISPR J; 2023 Oct; 6(5):473-485. PubMed ID: 37676985
[TBL] [Abstract][Full Text] [Related]
10. Optical Genome Mapping Reveals Genomic Alterations upon Gene Editing in hiPSCs: Implications for Neural Tissue Differentiation and Brain Organoid Research.
Gallego Villarejo L; Gerding WM; Bachmann L; Hardt LHI; Bormann S; Nguyen HP; Müller T
Cells; 2024 Mar; 13(6):. PubMed ID: 38534351
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells.
Sharma A; Toepfer CN; Ward T; Wasson L; Agarwal R; Conner DA; Hu JH; Seidman CE
Curr Protoc Hum Genet; 2018 Jan; 96():21.11.1-21.11.20. PubMed ID: 29364519
[TBL] [Abstract][Full Text] [Related]
13. FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells.
Caillaud A; Lévêque A; Thédrez A; Girardeau A; Canac R; Bray L; Baudic M; Barc J; Gaborit N; Lamirault G; Gardie B; Idriss S; Rimbert A; Le May C; Cariou B; Si-Tayeb K
STAR Protoc; 2022 Dec; 3(4):101680. PubMed ID: 36115027
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines.
Sanjurjo-Soriano C; Erkilic N; Mamaeva D; Kalatzis V
Methods Mol Biol; 2022; 2454():589-606. PubMed ID: 33755901
[TBL] [Abstract][Full Text] [Related]
15. Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones.
Frank E; Cailleret M; Nelep C; Fragner P; Polentes J; Herardot E; El Kassar L; Giraud-Triboult K; Monville C; Ben M'Barek K
Stem Cell Res Ther; 2023 Apr; 14(1):110. PubMed ID: 37106426
[TBL] [Abstract][Full Text] [Related]
16. Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection.
Steyer B; Bu Q; Cory E; Jiang K; Duong S; Sinha D; Steltzer S; Gamm D; Chang Q; Saha K
Stem Cell Reports; 2018 Feb; 10(2):642-654. PubMed ID: 29307579
[TBL] [Abstract][Full Text] [Related]
17. Precise and efficient scarless genome editing in stem cells using CORRECT.
Kwart D; Paquet D; Teo S; Tessier-Lavigne M
Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
[TBL] [Abstract][Full Text] [Related]
18. One-Step Generation of Seamless Luciferase Gene Knockin Using CRISPR/Cas9 Genome Editing in Human Pluripotent Stem Cells.
Li M; Hunt JFVS; Bhattacharyya A; Zhao X
Methods Mol Biol; 2019; 1942():61-69. PubMed ID: 30900175
[TBL] [Abstract][Full Text] [Related]
19. A Cell-Based Optimised Approach for Rapid and Efficient Gene Editing of Human Pluripotent Stem Cells.
Cuevas-Ocaña S; Yang JY; Aushev M; Schlossmacher G; Bear CE; Hannan NRF; Perkins ND; Rossant J; Wong AP; Gray MA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373413
[TBL] [Abstract][Full Text] [Related]
20. A Method for Genome Editing in Human Pluripotent Stem Cells.
Smith C; Ye Z; Cheng L
Cold Spring Harb Protoc; 2016 Apr; 2016(4):pdb.prot090217. PubMed ID: 27037073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
